TRATAMENTO DE GESTANTES CONTAMINADAS COM COVID-19: SCOPING REVIEW

Autores

DOI:

https://doi.org/10.46551/rnm23173092202100107

Palavras-chave:

Gravidez, Infecções por coronavírus, COVID-19, Complicações Infecciosas na Gravidez, Tratamento Medicamentoso

Resumo

Objetivo: mapear as evidências acerca do tratamento de gestantes com confirmação diagnóstica de infecção pelo SARS-CoV-2. Método: revisão de escopo, conforme o Institute Joanna Briggs e o PRISMA-ScR, com buscas em quatro bases de dados; extração, análise e síntese por quatro pesquisadores independentes de forma descritiva. Resultados: das 553 publicações, selecionaram-se 28 artigos para análise, todos no idioma inglês. Observou-se que uma pequena parcela das gestantes utilizou oxigenoterapia e um número inferior necessitou de ventilação mecânica e monitorização em CTI. Os medicamentos mais utilizados no tratamento foram: antibióticos, antivirais e a corticoterapia. Considerações finais: não se encontraram protocolos ou padronização de medicamentos no tratamento da gestante com COVID-19.

nsiderações finais: Não encontrou-se protocolos ou padronização de medicamentos no tratamento da gestante com COVID-19.

Downloads

Não há dados estatísticos.

Biografia do Autor

Karoline Faria de Oliveira, Universidade Federal do Triângulo Mineiro, Uberaba, MG, Brasil

Doutora em Atenção à Saúde pela Universidade Federal do Triângulo Mineiro – UFTM, Universidade Federal do Triângulo Mineiro, Uberaba, MG, BR

Jacqueline Faria de Oliveira, Hospital de Clínicas da Universidade Federal do Triângulo Mineiro, Uberaba, MG, BR.

Doutora em Atenção à Saúde pela Universidade Federal do Triângulo Mineiro – UFTM, Universidade Federal do Triângulo Mineiro, Uberaba, MG, BR

Monika Wernet, Universidade Federal de São Carlos, São Carlos, SP, BR

Pós doutora em Ciências da Saúde pela Universidade de São Paulo, Universidade Federal de São Carlos, São Carlos, SP, BR

Marina Carvalho Paschoini, Universidade Federal do Triângulo Mineiro, Uberaba, MG, Brasil

Doutora em tocoginecologia pela Faculdade de Medicina de Ribeirão Preto – Universidade de São Paulo, Universidade Federal do Triângulo Mineiro, Uberaba, MG, BR

Mariana Torreglosa Ruiz, Universidade Federal do Triângulo Mineiro, Uberaba, MG, Brasil

Doutora em Enfermagem em Saúde Pública pela Escola de Enfermagem de Ribeirão Preto – Universidade de São Paulo, Universidade Federal do Triângulo Mineiro, Uberaba, MG, BR

Referências

Whitehead CL, Walker SP. Consider pregnancy in COVID-19 therapeutic drug and vaccine trials. Lancet. 2020; 395: e92. doi: 10.1016/S0140-6736(20).31029-1.

Karlsen APH, Wiberg S, Laigaard J, Pedersen C, Rokamp KZ, Mathiesen O. A systematic review of trial registry entries for ramdomized clinical trials investigating COVID-19 medical prevention and treatment. PLoS One. 2020; 15 (8):e0237903. doi: 10.1371/jornal.pone. 0237903

Knight M, Morris KR, Furniss J, Chappell LC. Include pregnant women in research – particularly COVID-19 research. BMJ. 2020; 370: m3305. doi: 10.1136/bmj.m3305

Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun HL, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018; 169 (7): 467-73. doi: 10.7326/M18-0850

Lockwood C, Tricco AC. Preparing scoping reviews for publication using methodological guides and reporting standards. Nurs Healh Sci. 2020; 22:1-4. doi: 10.1111/nhs.12673.

Joanna Briggs Institute. Joanna Briggs Institute Reviewers’ Manual: 2014 Edition. Adelaide: The University of Adelaide. https://nursing.lsuhsc.edu/JBI/docs/ReviewersManuals/ReviewersManual.pdf

Chen H, Guo J, Wang C, Lou F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet. 2020; 395: 809-15. doi: 10.1016/S0140-6736(20)30360-3

Kalafat E, Yaprak E, Cinar G, Varli B, Ozisik S, Uzun C, et al. Lung ultrasound and computed tomographic findings in pregnant woman with COVID-19. Ultrasound Obstet Gynecol. 2020;55(6):835-837. doi: 10.1002/uog.22034.

Alzamora MC, Paredes T, Caceres D, Webb CM, Valdez LM, La Rosa M. Severe COVID-19 during pregnancy and possible vertical transmission. Am J Perinatol. 2020; 37(8):861-865. doi: 10.1055/s-0040-1710050

Peng Z, Wang J, Mo Y, Duan W, Xiang G, Yi M, et al. Unlikely SARS-CoV-2 vertical transmission from mother to child: A case report. J Infect Public Health. 2020; 13(5):818-820. doi: 10.1016/j.jiph.2020.04.004

Iqbal SN, Overcash R, Mokhtari N, Saeed H, Gold S, Auguste T, et al. An uncomplicated delivery in a patient with COVID-19 in the United States. N Engl J Med. 2020; 382(16):e34. doi: 10.1056/nejmc2007605

Wen R, Sun Y, Xing QS. A patient with SARS-CoV-2 infection during pregnancy in Qingdao, China. J Microbiol Immunol Infect. 2020; 53 (3): 499-500. doi: 10.1016/j.jmii.2020.03.004

Knight M, Bunch K, Vousden N, Morris E, Simpson N, Gale C, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020. doi: 10.1101/2020.05.08.20089268

Lowe B, Bopp B. COVID-19 vaginal delivery – a case report. Aust N Z J Obstet Gynaecol. 2020; 1–2. doi: 10.1111/ajo.13173

Rosen MH, Axelrad J, Hudesman D, Rubin DT, Chang S. Management of acute severe ulcerative colitis in a pregnant woman with COVID-19 infection: a case report and review of the literature. Inflamm Bowel Dis. 2020. 18;26(7):971-973. doi: 10.1093/ibd/izaa109

Hantoushzadeh S, Shamshirsaz AA, Aleyasin A, Seferovic MD, Aski SK, Arian SE, et al. Maternal death due COVID-19. Am J Obstet Gynecol. 2020; 223: 109.e1-e16. doi: 10.1016/j.ajog.2020.04.030

Pereira A, Cruz-Melguizo S, Adrien M, Fuentes L, Marin E, Perez-Medina T. Clinical course of coronavirus disease – 2019 (COVID-19) in pregnancy. Acta Obstet Gynecol Scand. 2020; 99(7):839-847. doi: 10.1111/AOGS.13921

Lyra J, Valente R, Rosario M, Guimarães M. Cesarean section in a pregnant woman with COVID-19: first case in Portugal. Acta Med Port. 2020; 33 (6): 429-31. doi: 10.20344/amp.13883

Blauvelt CA, Chiu C, Donovan AL, Prahl M, Shimotake TK, George RB, et al. Acute respiratory distress syndrome in a preterm pregnant patient with coronavirus disease 2019 (COVID-19). Obstet Gynecol. 2020; 136 (1): 46-51. doi: 10.1097/AOG.0000000000003949

Browne PC, Linfert JB, Perez-Jorge E. Sucessful treatment of preterm labor in association with acute COVID-19 infection. Am J Perinatol. 2020; 37: 866-868. doi: 10.1055/s-0040-1709993

Grimminck K, Santegoets LAM, Siemens FC, Fraaij PLA, Reiss IKM, Schoenmakers S. No evidence of vertical transmission of SARS-CoV-2 after induction of labour in an immune-suppressed SARS-CoV-2-positive patient BMJ. 2020; 13:e235581. doi:10.1136/bcr-2020-235581

Vallejo V, Ilagan JG. A postpartum death due to coronavirus disease 2019 (COVID-19) in the United States. Obstet Gynecol. 2020; 136: 52-55. doi: 10.1097/AOG.0000000000003950

Ferraiolo A, Barra K, Kratochwila C, Paudice M, Vellone VG, Godano E, et al. Report of positive placental swabs for SARS-CoV-2 in an asymptomatic pregnant woman with COVID-19. Medicina. 2020, 56, 306; doi:10.3390/medicina56060306

Qadri F, Mariona F. Pregnancy affected by SARSCoV-2 infection: a flash report from Michigan. J Matern Fetal Neonatal Med. 2020; 20: 1-3. doi: 10.1080/14767058.2020.1765334

Lu D, Sang L, Du S, Li T, Chang Y, Yang X. Asymptomatic COVID-19 infection in late pregnancy indicated no vertical transmission. J Med Virol. 2020. doi: 10.1002/jmv.25927

Xiong X, Wei H, Zhang Z, Chang J, Ma X, Gao X, et al. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. J Med Virol. 2020. doi: 10.1002/jmv.25857.

Silverstein JS, Limaye MA, Brubaker SG, Roman AS, Bautista J, Chervenak J, et al. Acute respiratory decompensation requiring intubation in pregnant women with SARS-CoV-2 (COVID-19). Am J Perinatol Rep. 2020; 10:e169–e175. doi:10.1055/s-0040-1712925

Futterman I, Toaff M, Navi L, Clare CA. COVID-19 and HELLP: overlapping clinical pictures in two gravid patients. Am J Perinatol Rep. 2020;10:e179–e182. doi: 10.1055/s-0040-1712978

Koumoutsea EV, Vivanti AJ, Shehata N, Benachi A, Gouez AL, Desconclois C. COVID-19 and acute coagulopathy in pregnancy. J Thromb Haemost. 2020;18:1648–1652. doi: 10.1111/jth.14856

Wu Y, Liu C, Dong L, Zhang C, Chen Y, Liu J, et al. Coronavirus disease 2019 among pregnant Chinese women: case series data on the safety of vaginal birth and breastfeeding. BJOG 2020; 127:1109–1115. doi: 10.1111/1471-0528.16276

Zeng Y, Lin L, Yan Q, Wei W, Yang BX, Huang R, et al. Update on clinical outcomes of women with COVID‐19 during pregnancy. Int J Gynaecol Obstet. 2020; 150 (2): 264-266. doi: 10.1002/ijgo.13236

Yu Y, Fan C, Bian J, Shen Y. Severe COVID‐19 in a pregnant patient admitted to hospital in Wuhan. Int J Gynaecol Obstet. 2020; 150 (2): 262-263. doi: 10.1002/ijgo.13232

Liu D, Li L, Wu X, Zheng D, Wang J, Yang L, et al. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. AJR. 2020; 215: 127-132. doi: 10.2214/AJR.20.23072

Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X, et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study Lancet Infect Dis 2020; 20: 559–64. doi: 10.1016/ S1473-3099(20)30176-6

Poon LC, Yang H, Kapur A, Melamed N, Dao B, Divakar H, et al. Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: information for healthcare professionals. Int J Gynaecol Obstet. 2020; 149 (3): 273-86. doi: 10.1002/ijgo.1356

Royal College of Obstetricians & Gynaecologists. The Royal College of Midwives. Coronavirus (COVID-19) Infection in pregnancy.[Internet] 2020 [cited 2020 May 18]. Available from: rcog.org.uk/globalassets/documents/guidelines/2020-04-03-coronavirus-covid-19-infection-in-pregnancy.pdf

Rasmussen AS, Smulian JC, Lidnicky JA, Wen TS, Jamieson DJ. Coronavirus disease 2019 (COVID-19) and pregancy: whats obstetrcians need to know. Am J Obst Gynecol. 2020; 222 (5): 415-26. doi: 10.1016/j.ajog.2020.02.017

Chua MSQ, Lu JCS, Sulaiman S, Tan HK. From the frontline of COVID-19 – how prepared are we as obstetricians? A commentary. BJOG. 2020; 127:786-788. doi: 10.111/1471-0528.16192

Smith V, Seo D, Warty R, Payne O, Salih M, Chin KL, et al. Maternal and neonatal outcomes associated with COVID-19 infection: a systematic review. PLOs One. 2020; 15(6): e0234187. doi: 10.1371/jornal.pone.0234187

Gildlof S, Savchenko J, Brune T, Joefson H. COVID-19 in pregnancy with comorbidities: more liberal testing strategy is needed. Acta Obst Gynecol Scand. 2020; 99 (7): 948-9. doi: 10.111/aogs.13862

Qi H, Luo X, Zheng Y, Zhang H, Li J, Zou L, et al. Safe delivery for pregnancies affected by COVID-19. BJOG. 2020; 127: 927-929. doi: 10.1111/1471-0528.16231

ISUOG. ISUOG interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium: information for healthcare professional – an update. Ultrassound Obstet Gynecol. 2020; 55: 848-862. doi: 10.1002/uog.22061

Dashraat P, Wong JLJ, Lim MXK, Lim LM, Li S, Biswas A, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol. 2020; 222 (6): 521-531. doi: 10.1016/j.ajog.2020.03.021.

Di Marcio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020; 2 (2): 100107. doi: 10.1016/jajogmfm.2020.100107

Panahi L, Amiri M, Pouy S. Risks of novel coronavirus disease (COVID-19) in pregnancy, a narrative review. Arch Acad Emerg Mede. [Internet] 2020 [cited 2020 Jun 12]; 8 (1): e34. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092922/pdf/aaem-8-e34.pdf

Chen L, Li Q, Zheng D, Jiang H, Wei Y, Zou L, et al. Clinical characteristics of pregnant women with COVID-19 in Wuhan, China. N Engl J Med. 2020. doi: 10.1056/NEJMc2009226.

Ellington S, Strid P, Tong VT, Woodworth K, Galang RR, Zambrano LD. Characteristics of women of reproductive age with laboratory-confirmed SARS-Cov-2 infection by pregnant status, United States, January 22-June7, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69 (25): 769-775.

Collin J, Bystrom E, Carnahan AS, Ahrme M. Public Health Agency of Sweden’s brief report: pregnant and postpartum women with SARS-CoV-2 infection in intensive care in Sweden. Acta Obstet Gynecol Scand. 2020. doi: 10.1111/aogs.13901

Mullins E, Evans D, Viner RM, O’Brien P, Morris E. Coronavirus in pregnancy and delivery: rapid review. Ultrasound Obstet Gynecol. 2020; 55 (5): 586-92. doi: 10.1002/uog.22014

Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: a systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020; 99 (7): 823-9. doi: 10.1111/aogs.13867

Takemoto LS, Menezes MO, Andreucci CB, Nakamura-Pereira M, Amorim MMR, Katz L, et al. The tragedy of COVID-19 in Brazil: 124 maternal deaths and couting. Int J Gynecol Obstet. 2020. doi: 10.1002/ijgo.13300

Quiancheng X, Jian S, Lingling P, Lei H, Xiaogan J, Weihua L, et al. Coronavirus disease 2019 in pregnancy. Int J Infect Dis. 2020; 95: 376-383. doi: 10.1016/j.ijid.2020.04.065

Zhao X, Jiang Y, Zhao Y, Xi H, Liu C, Qu F, Feng X. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening. Eur J Clin Microbiol Infect Dis. 2020. doi: 10.1007/s10096-02003897-6

World Health Organization. Novel coronavirus technical guidance: patient management. 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/patient-management.

Sichitiu J, Desseauve D. Antenatal corticoesteroid therapy and COVID-19: pathophysiological considerations. Acta Obstet Gynecol Scand.2020; 00:1. doi: 10.1111/aogs.13887

McIntosh JJ. Corticoesteroid guidance for pregnacy during COVID-19 pandemic Am J Perinatol. 2020; 37 (8):809-12. doi: 10.1055/s-0040-17094

Karimi-Zarchi M, Neamatzadeh H, Datgheib AS, Abbasi H, Mirjalili SR, Behforouz A, et al. Vertical transmission of coronavirus disesase 19 (COVID-19) from infected pregnant mothers to neonates: a review. Fetal Pediatr Pathol. 2020; 39 (3): 246-50. doi: 10.1080/15513815.2020.1747120

Cancino KD, Arias M, Caballero E, Escudero E. Development of a safe drug administration assessment instrument for nursing students. Rev. Latino-Am. Enfermagem. 2020; 28: e3246. doi: 10.1590/1518-8345.2989.3246.

Publicado

03-09-2021

Como Citar

de Oliveira, K. F., de Oliveira, J. F., Wernet, M., Paschoini, M. C., & Torreglosa Ruiz, M. (2021). TRATAMENTO DE GESTANTES CONTAMINADAS COM COVID-19: SCOPING REVIEW. Revista Renome, 10(1), 65–75. https://doi.org/10.46551/rnm23173092202100107